Shaping the Future of PD Treatment
Together, we're working to understand why PD affects people differently -- and how to stop the disease.
Leading the Way to Precision Parkinson's Care
People with and without Parkinson's disease (PD) are transforming the future of care by joining the LITE study. LITE (LRRK2 Investigative Therapeutic Exchange) is learning more about the disease to drive new, personalized therapies.
Fast Facts about LITE
Read about LITE
Created in Partnership with Volunteers
Travel costs are covered, and study visits are flexible. See how you can help drive discoveries.
Partnering with Sites across the World
Sites across the U.S., Europe, Asia and Israel are partnering with people with and without PD.
Be a Part of Progress
LITE is a research study led by the University of Dundee and supported by The Michael J. Fox Foundation for Parkinson's Research. The study partners with people with and without Parkinson's disease. It tests for changes in the LRRK2 pathway. Changes in this gene are linked to PD.
By collecting biological samples and health information, LITE aims to identify new ways to measure Parkinson's and test new therapies. Your participation will help researchers develop better tools and treatments -- and move us closer to stopping Parkinson's altogether.
Ready to Join?
Whether you have Parkinson's, a family connection, or are simply curious about contributing to research -- you can make a difference.
Together, we can transform the future of Parkinson's.
